Danielle Leeper
Nurse Practitioner · Little Rock, ARNPI 1669924817
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 203 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Viiv Healthcare Company at 25.3% of the total. 2025 is the largest year on record at $1,737, more than ten times the $78 reported in 2022. Among nurse practitioner clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 203 payments — averaging $20.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$1K
- Gilead$583
- Merck$458
- AbbVie$423
- Paratek Pharmaceuticals, Inc.$286
- Melinta Therapeutics, LLC$265
- plus $1K from 9 others
What the payments were for
- Food & beverage$4,06397%
- Education$1453%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 57 | $1,066 |
| Gilead | 23 | $583 |
| Merck | 25 | $458 |
| AbbVie | 27 | $423 |
| Paratek Pharmaceuticals, Inc. | 15 | $286 |
| Melinta Therapeutics, LLC | 11 | $265 |
| Astellas Pharma US Inc | 8 | $244 |
| Insmed, Inc. | 11 | $230 |
| Theratechnologies Inc. | 6 | $180 |
| Shionogi Inc | 6 | $160 |
| Aimmune Therapeutics, Inc. | 5 | $141 |
| La Jolla Pharmaceutical Company | 4 | $72 |
| Johnson & Johnson | 3 | $57 |
| Nestle Healthcare Nutrition Inc. | 1 | $25 |
| Cumberland Pharmaceuticals, Inc. | 1 | $17 |
How this compares
$4,208 in reported general payments places this provider in the 90th percentile of 697 nurse practitioner providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 140 | $588,212 |
| DovatoDolutegravir Sodium/Lamivudine | 90 | $274,567 |
| JulucaDolutegravir/Rilpivirine | 50 | $182,034 |
| TivicayDolutegravir Sodium | 43 | $99,767 |
| PrezcobixDarunavir/Cobicistat | 30 | $76,616 |
| DescovyEmtricitabine/Tenofov Alafenam | 26 | $59,680 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 12 | $55,349 |
| PifeltroDoravirine | 14 | $25,770 |
| Rifabutin | 15 | $5,517 |
| Dicloxacillin Sodium | 45 | $3,441 |
| Fluconazole | 49 | $3,205 |
| Ampicillin Sodium | 36 | $2,714 |
| Rifampin | 19 | $2,619 |
| Itraconazole | 18 | $2,346 |
| Ethambutol Hcl | 59 | $2,303 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy | $583 | $647,891166 claims |
| Viiv Healthcare CompanyDovato, Juluca, Tivicay | $1,066 | $556,369183 claims |
| Johnson & JohnsonPrezcobix | $57 | $76,61630 claims |
| MerckPifeltro | $458 | $25,77014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 697 nurse practitioner providers in Arkansas.
Other nurse practitioner in Little Rock
- Iris KennedyLittle Rock$22K
- Julia PonderLittle Rock$21K
- Olivia CoxLittle Rock$14K
- Sarah AtkinsLittle Rock$12K
- Lauren ByersLittle Rock$8K
- Suzanne BroadwayLittle Rock$6K
- Natalie ByarsLittle Rock$6K
- Kristie CronkhiteLittle Rock$5K
- Mary GuellLittle Rock$5K
- Leigh JohnsonLittle Rock$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.